Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Other Non-Current Assets (2020 - 2025)

Pulse Biosciences (PLSE) has 6 years of Other Non-Current Assets data on record, last reported at $691000.0 in Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 2.07% year-over-year to $691000.0; the TTM value through Dec 2025 reached $691000.0, up 2.07%, while the annual FY2025 figure was $691000.0, 2.07% up from the prior year.
  • Other Non-Current Assets reached $691000.0 in Q4 2025 per PLSE's latest filing, down from $705000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $714000.0 in Q2 2024 and bottomed at $365000.0 in Q1 2021.
  • Average Other Non-Current Assets over 5 years is $476650.0, with a median of $365000.0 recorded in 2021.
  • Peak YoY movement for Other Non-Current Assets: crashed 35.05% in 2021, then skyrocketed 95.62% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $365000.0 in 2021, then changed by 0.0% to $365000.0 in 2022, then changed by 0.0% to $365000.0 in 2023, then surged by 85.48% to $677000.0 in 2024, then rose by 2.07% to $691000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Non-Current Assets were $691000.0 in Q4 2025, $705000.0 in Q3 2025, and $677000.0 in Q2 2025.